1)Wimmer CD, Angele MK, Schwarz B et al:Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation:a single center experience with 609 patients. Steunstichting ESOT 26:999-1006, 2013
2)Shields CL, Ramasubramanian A, Mellen PL et al:Conjunctival squamous cell carcinoma arising in immunosuppressed patients. Ophthalmology 118:2133-2137, 2011
3)Ebihara N, Ohashi Y, Fujishima H et al:Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. allergol int 61:275-282, 2012
4)Dua HS, Jindal VK, Gomes JA et al:The effect of topical cyclosporin on conjunctiva-associated lymphoid tissue. Eye 10:433-438, 1996
5)Tennis P, Gelfand JM, Rothman KJ:Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165:465-473, 2011
6)Rustin MH:The safety of tacrilimus ointment for the treatment of atopic dermatitis:a review. Br J Dermatol 157:861-873, 2007
7)Heinz C, Fanihagh F, Steuhl KP:Squamous cell carcinoma of the conjunctiva in patients with atopic eczema. Cornea 22:135-137, 2003
8)Flynn TH, Manzouri B, Tuft SJ:Ocular surface squamous neoplasia in an immunosuppressed patient with atopic keratoconjunctivitis. Int Ophthalmol 32:471-473, 2012
9)Rundle P, Mudhar HS, Rennie I:Conjunctival intra-epithelial neoplasia occurring in young patients with asthma. Eye 24:1182-1185, 2010
10)Robin R. Vann, MD, Carol L:Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 106:91-97, 1999
11)Shah US, Kaliki S, Kim JH et al:Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases. Arch Ophthalmol 131:159-164, 2012
12)Schechter BA, Koreishi AF, Karp CL et al:Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology 115:1291-1296, 2008